Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 63.34.
Forward PE Ratio (63.34) = Close Price ($94.77) / Consensus Forward EPS ($1.50)
FORWARD PE RATIO
63.34
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+218.05%
vs the sector median at left
TransMedics Group, Inc.
Market Cap
$3.28B
Forward PE Ratio
63.34
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| TransMedics Group, Inc. (TMDX) | $3.28B | 63.34 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.19B | 7.14 |
| Teladoc Health, Inc. (TDOC)vs › | $1.16B | N/A |
| NRC Health (NRC)vs › | $500.09M | 25.22 |
| Shoulder Innovations, Inc. (SI)vs › | $457.49M | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.54B | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.31B | 18.58 |
| Henry Schein, Inc. (HSIC)vs › | $10.08B | 16.44 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.23B | 39.42 |
| Insulet Corp. (PODD)vs › | $10.26B | 22.78 |
Trailing P/E
24.6
reported TTM EPS
Forward P/E
63.3
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.50 implies -61.1% EPS decline vs the reported trailing $3.86.
At today's $94.77 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.50 | $1.48 – $1.57 | 6 | 63.3x |
| 2027-12-31 | $2.30 | $1.72 – $2.62 | 8 | 41.2x |
| 2028-12-31 | $3.23 | $2.45 – $4.04 | 6 | 29.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
